Specimen index
Peptide Database
10 peptides — filtered results
BPC-157
PreclinicalBody Protection Compound 157 · PL 14736
BPC-157 is a 15-amino-acid peptide fragment derived from human gastric juice. It is one of the most extensively researched peptides for tissue repair, demonstrating accelerated healing of tendons, ligaments, muscle, bone, and gut lining in animal models. It appears to upregulate growth hormone receptors and promote angiogenesis at injury sites.
C₆₂H₉₈N₁₆O₂₂ · 1419.55 Da
CJC-1295
PreclinicalCJC-1295 with DAC · DAC:GRF
CJC-1295 is a modified GHRH analog with a Drug Affinity Complex (DAC) that binds to serum albumin, dramatically extending its half-life compared to native GHRH. It produces sustained elevation of GH and IGF-1 levels over days rather than hours. Research focuses on body composition improvements, muscle growth, and fat loss through prolonged GH axis stimulation.
C₁₅₂H₂₅₂N₄₂O₄₂S · 3647.28 Da
Epithalon
PreclinicalEpitalon · Epithalamin
Epithalon is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) modeled on the endogenous pineal peptide epithalamin. It is one of the most extensively studied longevity peptides, with Russian research demonstrating telomerase activation, telomere elongation, melatonin normalization, and extended lifespan in animal models. Long-term human studies show reduced all-cause mortality rates and improved biomarkers of aging.
Hexarelin
Phase IIExamorelin · EP 23905
Hexarelin is one of the most potent synthetic GHRP compounds, producing the largest GH pulse among GHRPs. Beyond its GH-stimulating properties, research highlights direct cardioprotective effects through CD36 receptor binding, independent of GH or IGF-1. Studies show benefits in heart failure models, myocardial infarction recovery, and protection against ventricular dysfunction.
Ipamorelin
PreclinicalNNC 26-0161
Ipamorelin is a selective growth hormone secretagogue and ghrelin receptor agonist. Unlike other GHRPs, it stimulates GH release with high selectivity — producing minimal cortisol, ACTH, or prolactin elevation. It is among the most studied GHRPs for its clean GH pulse profile, making it a preferred research peptide for GH axis studies with reduced side effect concern.
C₃₈H₄₉N₉O₅ · 711.86 Da
PT-141
ApprovedBremelanotide · Vyleesi
PT-141 (bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist, FDA-approved for hypoactive sexual desire disorder (HSDD) in premenopausal women. Unlike PDE5 inhibitors, it acts centrally through MC3R and MC4R receptors in the hypothalamus to initiate sexual arousal, making it effective for psychological as well as physiological sexual dysfunction. Research also explores applications in male erectile dysfunction.
Sermorelin
ApprovedGHRH(1-29) · GRF 1-29 NH2
Sermorelin is a synthetic analog of the first 29 amino acids of endogenous growth hormone-releasing hormone (GHRH). It stimulates the pituitary to produce and secrete growth hormone in a pulsatile, physiologic manner. FDA-approved for GH deficiency in children, it is extensively researched in adults for body composition, sleep quality, and age-related GH decline.
C₁₄₉H₂₄₆N₄₄O₄₂S · 3357.88 Da
TB-500
PreclinicalThymosin Beta-4 Fragment · Tβ4 fragment
TB-500 is a synthetic version of the active region of Thymosin Beta-4, a naturally occurring peptide found in virtually all human cells. Research shows it promotes actin polymerization and cell migration, which accelerates wound healing, muscle repair, and vascular growth. It is particularly studied for its ability to reduce inflammation and promote cardiac tissue repair.
C₂₁₂H₃₅₀N₅₆O₇₈S · 4963.44 Da
Tesamorelin
ApprovedEgrifta · TH9507
Tesamorelin is a stabilized synthetic GHRH analog FDA-approved for reduction of excess abdominal fat in HIV-infected adults with lipodystrophy. It stimulates pulsatile GH secretion while preserving natural feedback regulation. Research demonstrates significant visceral adipose tissue reduction, improved lipid profiles, and cognitive benefits, making it a key study compound for metabolic dysfunction.
Thymosin Alpha-1
ApprovedThymalfasin · Tα1
Thymosin Alpha-1 is a naturally occurring 28-amino-acid peptide derived from thymosin fraction 5 of the thymus gland. Approved in over 35 countries for hepatitis B, hepatitis C, and as an immune adjuvant in cancer therapy, it enhances T-cell maturation, dendritic cell function, and NK cell activity. Research continues to expand into sepsis, COVID-19, autoimmune conditions, and vaccine response enhancement.
C₁₂₉H₂₁₅N₃₃O₅₅ · 3108.29 Da